HBI
58
2
ADBE
55
4
MKC
51
-2
CA
32
3
IVZ
50
2
FAST
42
-2
BWA
45
3
IFF
45
-2
FOXA
66
-3
BK
65
2
PSX
29
2
ADT
32
4
MSI
55
-2
WBA
44
6
KMB
33
2
ROST
66
4
ESS
51
3
STZ
40
-2
KEY
30
3
KR
52
2
HBI
58
2
ADBE
55
4
MKC
51
-2
CA
32
3
IVZ
50
2
FAST
42
-2
BWA
45
3
IFF
45
-2
FOXA
66
-3
BK
65
2
PSX
29
2
ADT
32
4
MSI
55
-2
WBA
44
6
KMB
33
2
ROST
66
4
ESS
51
3
STZ
40
-2
KEY
30
3
KR
52
2
Financhill
Back

uniQure NV 10K Form

Buy
64

QURE
uniQure NV

Last Price:
$17.73
Seasonality Move:
8.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive QURE News And Ratings

See the #1 stock for the next 7 days that we like better than QURE

QURE Financial Statistics

Sales & Book Value

Annual Sales: $15.8M
Cash Flow: $-45.3M
Price / Cash Flow: 0
Annual Sales: $1.15
Price / Book: 15.48

Profitability

EPS (TTM): -4.96000
Net Income (TTM): $-239.5M
Gross Margin: $2.2M
Return on Equity: -154.29%
Return on Assets: -31.11%

uniQure NV Earnings Forecast

Key uniQure NV Financial Ratios

  • The Gross Profit Margin over the past 13 years for QURE is 13.98%.
  • The Selling, General & Administrative Expenses for QURE have been equal to 470.81% of Gross Profit Margin.
  • The Research & Development expenses have been 1,356.21% of Revenue.
  • The Interest Expense is -13.47% of Operating Income.
  • The Net Earning history of QURE is -1,947.09% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

uniQure NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: QURE
CUSIP: N90064
Website: uniqure.com

Debt

Debt-to-Equity Ratio: 0.92
Current Ratio: 6.51
Quick Ratio: 6.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

QURE Technical Analysis vs Fundamental Analysis

Buy
64
uniQure NV (QURE) is a Buy

Is uniQure NV a Buy or a Sell?

  • uniQure NV stock is rated a Buy
    The current uniQure NV [QURE] share price is $17.73. The Score for QURE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.